One of the major platform technologies of our clinical research program focuses on the use of state-of-the-art cardiopulmonary exercise testing (CPET) technology, a robust and powerful technology that can accurately and reproducibly assess cardiovascular functional capacity. We are at the forefront of efforts to introduce CPET technology into the field of nephrology. The potential exists for CPET indices such as VO2Peak to be used as a new endpoint for cardiovascular trials in nephrology which can help overcome current challenges in cardio-renal trials due to the existing limitations of resting cardiac endpoints. The technology has the potential to help move the cardio-renal field forward.
Founded by Dr. Lim, our CPET laboratory is the first of its kind dedicated to the study of patients with kidney disease in the United States. Our state-of-the-art CPET machine linked to two cycle ergometers for symptom-limited exercise testing dedicated to research in patients with kidney patients. We perform breath-by-breath analysis using a state-of-the-art metabolic cart (VyntusTM CPX Metabolic Cart, Vyaire Medical). Our CPET machine is fully equipped with a non-invasive cardiac output monitor (using signal morphology impedance cardiography, Physioflow). Our cardiac output monitor is synchronized with our metabolic cart at the start of the exercise testing and this enables us to accurately track in real time cardiac changes throughout the exercise testing cycle. Further cardiac monitoring equipment includes 12-lead EKG, cardiac output monitoring, blood pressure and oxygen saturation monitoring system. As part of our CPET set-up, we have both an upright and recumbent bike (the latter which is more user friendly for older patients).